Steinert
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 (NCT07486934) | Dyne Therapeutics | 2026-05-14 |
| Global Study of Del-desiran for the Treatment of DM1 (NCT06411288) | Avidity Biosciences, Inc. | 2024-05-30 |
Track Steinert automatically
Every clearance here is in the API, with alerts when new ones post.